Annexon Inc (ANNX)
4.335
-0.02
(-0.57%)
USD |
NASDAQ |
May 17, 16:00
4.335
0.00 (0.00%)
After-Hours: 20:00
Annexon Cash from Investing (Quarterly): -77.30M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -77.30M |
| December 31, 2023 | -2.183M |
| September 30, 2023 | 47.84M |
| June 30, 2023 | 5.531M |
| March 31, 2023 | 19.52M |
| December 31, 2022 | -43.62M |
| September 30, 2022 | 14.10M |
| June 30, 2022 | 19.71M |
| March 31, 2022 | 68.25M |
| December 31, 2021 | 33.70M |
| Date | Value |
|---|---|
| September 30, 2021 | -1.278M |
| June 30, 2021 | -83.07M |
| March 31, 2021 | -37.58M |
| December 31, 2020 | -82.87M |
| September 30, 2020 | -0.276M |
| June 30, 2020 | -0.016M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.099M |
| September 30, 2019 | -0.15M |
| June 30, 2019 | -0.018M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-83.07M
Minimum
Jun 2021
68.25M
Maximum
Mar 2022
-5.991M
Average
-0.0585M
Median
Cash from Investing (Quarterly) Benchmarks
| Trxade Health Inc | -0.35M |
| P3 Health Partners Inc | 0.00 |
| Arrowhead Pharmaceuticals Inc | -268.94M |
| Insmed Inc | 295.32M |
| Heron Therapeutics Inc | 1.278M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -28.27M |
| Cash from Financing (Quarterly) | 32.41M |
| Free Cash Flow | -116.42M |
| Free Cash Flow Per Share (Quarterly) | -0.2304 |
| Free Cash Flow Yield | -30.60% |